Anna Legedza

Anna Legedza has over 30 years of diverse work experience in the fields of biostatistics, modeling and simulation, and consulting. Anna is currently the Director of Biostatistics at Lyndra Therapeutics, a position they have held since March 2022. Prior to this, Anna worked at Alkermes as a Director of Biostatistics from December 2017 to June 2021. Anna also has a strong background in the pharmaceutical industry, having worked at Vertex Pharmaceuticals in various roles, including Associate Director, Interim Head of Modeling & Simulation, and Principal Biostatistician, among others. Anna also has experience in academia, having held a position as an Associate Biostatistician and Instructor at Beth Israel Deaconess Medical Center & Harvard Medical School. Anna began their career as a Staff Consultant at Price Waterhouse. Additionally, Anna has a musical background as a former board member and violinist in the Longwood Symphony Orchestra.

Anna Legedza completed their education in a chronological manner, starting with an undergraduate degree in Mathematics from Princeton University between 1986 and 1990. Anna then pursued a Master's degree in Statistics from Carnegie Mellon University from 1992 to 1994. Following that, Anna attended Harvard T.H. Chan School of Public Health, where they earned a Doctor of Science (Sc.D.) degree in Biostatistics from 1994 to 2000. Lastly, they continued their academic journey at the same institution and completed a postdoctoral fellowship in Biostatistics from 1999 to 2001.